BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34452401)

  • 1. Detection of Human Papillomavirus Integration in Brain Metastases from Oropharyngeal Tumors by Targeted Sequencing.
    McEllin B; Searle BC; DePledge L; Sun G; Cobbs C; Karimi M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N
    Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
    Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study.
    Bulut OC; Lindel K; Hauswald H; Brandt R; Klauschen F; Wolf J; Wolf T; Plinkert PK; Simon C; Weichert W; Stenzinger A
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1715-22. PubMed ID: 23990032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
    Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
    Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
    Huebbers CU; Verhees F; Poluschkin L; Olthof NC; Kolligs J; Siefer OG; Henfling M; Ramaekers FCS; Preuss SF; Beutner D; Seehawer J; Drebber U; Korkmaz Y; Lam WL; Vucic EA; Kremer B; Klussmann JP; Speel EM
    Int J Cancer; 2019 May; 144(10):2465-2477. PubMed ID: 30367463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oropharyngeal cancers: significance of HPV16 detection in neck lymph nodes.
    Mirghani H; Ferchiou M; Moreau F; Vourexakis Z; Amen F; Breuskin I; Lefèvre M; Casiraghi O; Drusch F; Soussan P; Vielh P; St Guily JL
    J Clin Virol; 2013 Jun; 57(2):120-4. PubMed ID: 23478163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
    Eggersmann TK; Baumeister P; Kumbrink J; Mayr D; Schmoeckel E; Thaler CJ; Dannecker C; Jeschke U; Nagler T; Mahner S; Sharaf K; Gallwas JKS
    Anticancer Res; 2020 Apr; 40(4):2117-2123. PubMed ID: 32234904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence Changes of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma and Effects on Survival in the Netherlands Cancer Institute, 1980-2009.
    Henneman R; Van Monsjou HS; Verhagen CV; Van Velthuysen ML; Ter Haar NT; Osse EM; Lopez-Yurda MI; Balm AJ; Van Den Brekel MW
    Anticancer Res; 2015 Jul; 35(7):4015-22. PubMed ID: 26124350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
    Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
    J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.